Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a vaccine clear up severe teen acne?

NCT ID NCT07756957

Not yet recruiting ⭐️ VACCINE ⭐️ Sponsor: Sanofi Pasteur, a Sanofi Company Source: ClinicalTrials.gov ↗

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This trial is testing whether an experimental mRNA vaccine can safely reduce moderate-to-severe acne in adolescents aged 12 to 17. Participants receive either the vaccine at different dose levels or a placebo, and researchers monitor safety and changes in facial acne lesions. The study aims to see if this approach could offer a new way to treat acne by targeting its underlying causes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
An experimental mRNA vaccine designed to target acne-causing bacteria
What this could lead to
If successful, this could lead to a new vaccine-based approach to prevent or reduce severe acne in teenagers, potentially reducing the need for daily creams or antibiotics.
What could go wrong
This is an early-stage trial focused on safety, so it may not prove effective. The vaccine could cause side effects like injection-site reactions or systemic symptoms, and its benefit over placebo is not yet established.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACNE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acne Acne Vulgaris

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACNE

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.